Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety

Ischemic heart disease is a significant risk factor that threatens human health, and antiplatelet drugs are routinely used to treat cases in clinical settings. Chinese medicine for promoting blood circulation and removing blood stasis (PBCRBSCM) can often be combined with antiplatelet drugs to treat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zongliang Yu, Xiaoya Li, Xiaonan Zhang, Dan Li, Yimeng Gu, Min Wu, Longtao Liu
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Other systems of medicine RZ201-999
Acceso en línea:	https://doaj.org/article/a2bc4704f0d14b80a94a51cc6f01dfa5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a2bc4704f0d14b80a94a51cc6f01dfa5
record_format	dspace
spelling	oai:doaj.org-article:a2bc4704f0d14b80a94a51cc6f01dfa52021-11-08T02:37:01ZCombined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety1741-428810.1155/2021/9956248https://doaj.org/article/a2bc4704f0d14b80a94a51cc6f01dfa52021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/9956248https://doaj.org/toc/1741-4288Ischemic heart disease is a significant risk factor that threatens human health, and antiplatelet drugs are routinely used to treat cases in clinical settings. Chinese medicine for promoting blood circulation and removing blood stasis (PBCRBSCM) can often be combined with antiplatelet drugs to treat ischemic heart disease. PBCRBSCM can inhibit platelet adhesion, activation, and aggregation; moreover, PBCRBSCM in combination with antiplatelet drugs exerts antiplatelet effects. The mechanism is related to several factors, including the inhibition of platelet activation and aggregation, improvement of the hemodynamic status and coagulation function, and correction of metabolism and inflammation. PBCRBSCM can also regulate the absorption and metabolism of conventional antiplatelet drugs and protect the gastric mucosal epithelial cells against damage induced by conventional antiplatelet drugs. Randomized controlled trials have confirmed that PBCRBSCM preparations and the active ingredients in these preparations can reduce resistance to aspirin and clopidogrel so that the combination of these drugs can exert their antiplatelet effects. In the perioperative treatment of patients with stable angina pectoris, unstable angina pectoris, and acute coronary syndrome undergoing percutaneous coronary intervention therapy, preparations of the active ingredients of PBCRBSCM combined with antiplatelet drugs and other conventional Western medicine treatments have been proven effective. The efficacy and safety of such combinations have also been extensively verified. Considerable progress has been made to understand the antiplatelet mechanism of PBCRBSCM. However, most clinical studies had problems, such as limited sample size and inappropriate research design, which has limited the translational use of PBCRBSCM in antiplatelet therapy. A large-scale, multicenter, randomized controlled study with cardiovascular events as the endpoint is still to be conducted to provide evidence for the combined application of PBCRBSCM and antiplatelet drugs in the prevention and treatment of ischemic heart disease.Zongliang YuXiaoya LiXiaonan ZhangDan LiYimeng GuMin WuLongtao LiuHindawi LimitedarticleOther systems of medicineRZ201-999ENEvidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Other systems of medicine RZ201-999
spellingShingle	Other systems of medicine RZ201-999 Zongliang Yu Xiaoya Li Xiaonan Zhang Dan Li Yimeng Gu Min Wu Longtao Liu Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
description	Ischemic heart disease is a significant risk factor that threatens human health, and antiplatelet drugs are routinely used to treat cases in clinical settings. Chinese medicine for promoting blood circulation and removing blood stasis (PBCRBSCM) can often be combined with antiplatelet drugs to treat ischemic heart disease. PBCRBSCM can inhibit platelet adhesion, activation, and aggregation; moreover, PBCRBSCM in combination with antiplatelet drugs exerts antiplatelet effects. The mechanism is related to several factors, including the inhibition of platelet activation and aggregation, improvement of the hemodynamic status and coagulation function, and correction of metabolism and inflammation. PBCRBSCM can also regulate the absorption and metabolism of conventional antiplatelet drugs and protect the gastric mucosal epithelial cells against damage induced by conventional antiplatelet drugs. Randomized controlled trials have confirmed that PBCRBSCM preparations and the active ingredients in these preparations can reduce resistance to aspirin and clopidogrel so that the combination of these drugs can exert their antiplatelet effects. In the perioperative treatment of patients with stable angina pectoris, unstable angina pectoris, and acute coronary syndrome undergoing percutaneous coronary intervention therapy, preparations of the active ingredients of PBCRBSCM combined with antiplatelet drugs and other conventional Western medicine treatments have been proven effective. The efficacy and safety of such combinations have also been extensively verified. Considerable progress has been made to understand the antiplatelet mechanism of PBCRBSCM. However, most clinical studies had problems, such as limited sample size and inappropriate research design, which has limited the translational use of PBCRBSCM in antiplatelet therapy. A large-scale, multicenter, randomized controlled study with cardiovascular events as the endpoint is still to be conducted to provide evidence for the combined application of PBCRBSCM and antiplatelet drugs in the prevention and treatment of ischemic heart disease.
format	article
author	Zongliang Yu Xiaoya Li Xiaonan Zhang Dan Li Yimeng Gu Min Wu Longtao Liu
author_facet	Zongliang Yu Xiaoya Li Xiaonan Zhang Dan Li Yimeng Gu Min Wu Longtao Liu
author_sort	Zongliang Yu
title	Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
title_short	Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
title_full	Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
title_fullStr	Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
title_full_unstemmed	Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
title_sort	combined therapy with traditional chinese medicine and antiplatelet drugs for ischemic heart disease: mechanism, efficacy, and safety
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/a2bc4704f0d14b80a94a51cc6f01dfa5
work_keys_str_mv	AT zongliangyu combinedtherapywithtraditionalchinesemedicineandantiplateletdrugsforischemicheartdiseasemechanismefficacyandsafety AT xiaoyali combinedtherapywithtraditionalchinesemedicineandantiplateletdrugsforischemicheartdiseasemechanismefficacyandsafety AT xiaonanzhang combinedtherapywithtraditionalchinesemedicineandantiplateletdrugsforischemicheartdiseasemechanismefficacyandsafety AT danli combinedtherapywithtraditionalchinesemedicineandantiplateletdrugsforischemicheartdiseasemechanismefficacyandsafety AT yimenggu combinedtherapywithtraditionalchinesemedicineandantiplateletdrugsforischemicheartdiseasemechanismefficacyandsafety AT minwu combinedtherapywithtraditionalchinesemedicineandantiplateletdrugsforischemicheartdiseasemechanismefficacyandsafety AT longtaoliu combinedtherapywithtraditionalchinesemedicineandantiplateletdrugsforischemicheartdiseasemechanismefficacyandsafety
_version_	1718443027724238848

Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety

Ejemplares similares